Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Atrys Health SA ( (ES:ATRY) ) is now available.
Atrys Health SA reported significant growth in 2024, conducting over 9 million medical acts, marking an 18.5% increase from the previous year. The company’s expansion in health monitoring, tele-diagnoses, and oncology services underscores its strengthened market position and commitment to personalized healthcare solutions.
More about Atrys Health SA
Atrys is a global provider of health services, offering innovative and personalized solutions for patients. The company operates in various segments including tele-diagnoses, pathological anatomy, genetics, nuclear medicine, and oncology services, with a geographical presence in Spain, Portugal, Chile, Colombia, Peru, Brazil, and Mexico.
YTD Price Performance: -10.40%
Average Trading Volume: 245
Technical Sentiment Signal: Strong Buy
Current Market Cap: €234.8M
See more data about ATRY stock on TipRanks’ Stock Analysis page.